FDA Inspection 845938 — Fresenius Kabi Austria GMBH

Fresenius Kabi Austria GMBH — FEI 3003708554

The FDA completed an inspection of Fresenius Kabi Austria GMBH on Jul 16, 2013 in Graz. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 16, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Graz (Austria)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.